|
PFD-53739 |
VITAMINA E Epicon 400 UI Cápsulas de gelatina blanda |
2022-03-02 |
|
Epicon |
India
|
Epicon |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-54099 |
DICLOFENACO 50 mg + NEUROTROPAS , Renown Pharmaceuticals, cápsulas de gelatina blanda. |
2022-06-05 |
|
Renown Pharmaceuticals Pvt. Ltd. |
India
|
Epicon |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-45636 |
KETAL DUO Solución Inyectable |
2016-02-21 |
|
Schering Plough S.A.de C.V. |
Mexico
|
Amicelco |
Agencias J.I. Cohen |
Droguería Colón |
Refasa |
Merigal |
Droguería Y Farmacia Lanquetin |
Bodega Farmacéutica, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-47601 |
KETAL DUO 10 mg / 25 mg Cápsulas |
2017-07-23 |
|
Schering Plough S.A.de C.V. |
Mexico
|
Amicelco |
Agencias J.I. Cohen |
Droguería Colón |
Refasa |
Merigal |
Droguería Y Farmacia Lanquetin |
Bodega Farmacéutica, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-26531 |
Bencilpenicilina Sodica Cristalina Rimsa 1000000 UI polvo para inyecci |
2006-09-26 |
|
Representaciones E Investigaciones Medicas S.A. De C.V. |
Mexico
|
Servi-hospitales |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-26516 |
CARBAMAZEPINA Rimsa 200 mg. Tabletas |
2006-09-25 |
|
Representaciones E Investigaciones Medicas S.A. De C.V. |
Mexico
|
Servi-hospitales |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-26570 |
CEFTRIAXONA Rimsa 1g. polvo para solucion inyectable |
2006-10-24 |
|
Representaciones E Investigaciones Medicas S.A. De C.V. |
Mexico
|
Servi-hospitales |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-26515 |
CEFTAZIDIMA Rimsa 1g. polvo para solucion inyectable |
2006-09-25 |
|
Representaciones E Investigaciones Medicas S.A. De C.V. |
Mexico
|
Servi-hospitales |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-26568 |
METRONIDAZOL Rimsa 500 mg. Tabletas |
2006-10-24 |
|
Representaciones E Investigaciones Medicas S.A. De C.V. |
Mexico
|
Servi-hospitales |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-26569 |
DOPAMINA Rimsa 200 mg. Solucion inyectable |
2006-10-24 |
|
Representaciones E Investigaciones Medicas S.A. De C.V. |
Mexico
|
Servi-hospitales |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|